Fe65 Antibodies

Santa Cruz Biotechnology features a diverse variety of Fe65 Antibodies for advanced research in neuroscience and cellular signaling. Fe65 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fe65 is a multi-functional adaptor protein that plays a critical role in the signaling pathways associated with the amyloid precursor protein (APP), which is significant in Alzheimer's disease research. By mediating the interaction between APP and other signaling molecules, Fe65 is involved in processes such as neuronal differentiation and synaptic function. Understanding Fe65's role in cellular pathways is essential for elucidating the mechanisms underlying neurodegenerative diseases. Research has shown that Fe65 influences cellular processes through its ability to regulate gene expression and protein trafficking. Fe65's involvement in APP processing and nuclear signaling makes it a crucial target for understanding neurodegeneration mechanisms. Investigating Fe65's interactions with various binding partners provides insights into cellular communication and disease progression. Santa Cruz Biotechnology monoclonal antibodies for Fe65 support researchers worldwide in advancing our understanding of neurodegenerative diseases and potential therapeutic approaches.